Brief: Revive Therapeutics Announces LOI To Acquire Diagnamed’S Molecular Hydrogen Program

Diagnamed Holdings

03/03/2025 14:42

March 3 (Reuters) - DiagnaMed Holdings Corp DMED.CD:

REVIVE THERAPEUTICS ANNOUNCES LOI TO ACQUIRE DIAGNAMED’S MOLECULAR HYDROGEN PROGRAM

Source text: ID:nGNXCG5WM

Further company coverage: DMED.CD

 (Reuters.Briefs@thomsonreuters.com)